Skip to main content
Caplight Logo









Evoralis

Evoralis

Private
CambridgeEnergy & Sustainabilityhttps://www.evoralis.com/

Last Round

Seed

Sep 17, 2024

Total Funding Raised

$3.9M

Company Overview

Evoralis is a biotechnology company that develops plastic-depolymerizing enzymes for recycling.

Sector

Energy & Sustainability

Verticals

Biotechnology, Circular Economy, Sustainable Materials, Waste Management

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Infrastructure

Keywords

plastic depolymerizationenzymatic recyclingbiocatalystsmolecular recyclingbio-recyclingcircular economyenzyme discoverymicrofluidicsbiotechplastic waste managementprotein engineeringsynthetic biologytextile recyclingbioprocess licensinggreen chemistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evoralis Comparables

Compare Evoralis with similar companies based on industry and business-model similarity.

Evoralis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Entzimatiko S.L.
88%
Rhea's Factory
87%
Birch Biosciences
86%

Evoralis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 17, 2024
Convertible DebtJun 12, 2024

Key People

Founding team and executive leadership

Josephin Holstein

CTO

Executive Team

Evoralis Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2025

    Attended the Tech Tour Bio-based Industries 2025 event in Germany.

  • Jun 4, 2025

    Company is a spin-out from the University of Cambridge.

Recent news

Latest coverage and updates

  • attends_eventAug 18, 2026

    Evoralis will attend event Falling Walls Science Summit on Nov 1st '26.

  • recognized_asAug 18, 2026

    Evoralis recognized as one of the 25 finalists for Falling Walls Venture at Falling Walls Science Summit on Aug 18th '26.

  • recognized_asAug 18, 2026

    Evoralis recognized as finalist at Falling Walls Science Summit on Aug 18th '26.

Evoralis Filings

Explore SEC and related filing metadata, where available.

Evoralis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Evoralis's valuation, stock price, and market status.

Is Evoralis a public or private company?

Evoralis is a private company.

What is the current stock price of Evoralis?

Evoralis is a private company with no public stock price. No recent secondary market data is available.

How much is Evoralis worth (valuation)?

Valuation information for Evoralis is not publicly available.

Can I buy Evoralis stock?

Evoralis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Evoralis's last funding round?

Evoralis's most recent funding round was Seed on September 6, 2024.

Who are the main investors in Evoralis?

Key investors in Evoralis include Innovate UK.

Will Evoralis IPO soon?

No public IPO plans have been announced for Evoralis.

How can I track Evoralis secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Evoralis's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range17
Year Founded2021
Last FundingSep 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?